Cargando…
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome
Up to 10% of systemic lupus erythematosus (SLE) cases are drug-induced; hence, they are called drug-induced lupus syndrome (DILS). Antinuclear antibody (ANA) should be present to diagnose SLE and DILS. ANA-negative lupus is very rare; therefore, it presents a diagnostic challenge. In the medical lit...
Autores principales: | Solomon-Tsegaye, Theodros, Treadwell, Edward L., Obi, Reginald, Pitzalis, Mariavittoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267758/ https://www.ncbi.nlm.nih.gov/pubmed/30071945 http://dx.doi.org/10.5152/eurjrheum.2018.18040 |
Ejemplares similares
-
Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody
por: Iyer, Praneet, et al.
Publicado: (2017) -
An Antinuclear Antibody-Negative Patient With Lupus Nephritis
por: Kim, Hyoun-Ah, et al.
Publicado: (2009) -
Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies
por: Kannan, Lakshmi, et al.
Publicado: (2023) -
A Rare Case of Antinuclear Antibody (ANA)-Negative Lupus Nephritis
por: Bakshi, Nayaab, et al.
Publicado: (2023) -
Positive Antinuclear Antibody (ANA)-Negative Systemic Lupus Erythematosus (SLE) Presenting With Acute Pancreatitis
por: Samanta, Joydeep, et al.
Publicado: (2022)